Elevance Health ELV
Valuation
Multiples measured against the stock's own five-year history
Around its usual level · 55th percentile, 5-year average 17.2x
#1411 of 2972 stocks by PE (1 = cheapest)
Below its usual level · 28th percentile, 5-year average 2.6x
#3036 of 5311 stocks by PB (1 = cheapest)
Below its usual level · 25th percentile, 5-year average 0.6x
#880 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 2.03 | – | 2.56 | 28% (cheaper than usual) | #3036 of 5311 (1 = cheapest) |
| PE | 17.84 | 15.90 | 17.17 | 55% (pricier than usual) | #1411 of 2972 (1 = cheapest) |
| PS | 0.45 | 0.45 | 0.60 | 25% (cheaper than usual) | #880 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on ELV.
Sign in to join the discussion.